Deciphera Pharmaceuticals, Inc. Gains 72.56%
Mon, Apr 29, 2024 at 07:22 PM
Deciphera Pharmaceuticals, Inc. (DCPH:NASDAQ) jumped higher at $25.28, a gain of 72.6%. On Mon, Apr 29, 2024, DCPH:NASDAQ hit a New 2-Week High of $25.28. The stock got featured on our News Catalysts scanner on Mon, Apr 29, 2024 at 03:17 PM in the 'DOWNGRADE' category. From Mon, Apr 15, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
About Deciphera Pharmaceuticals, Inc. (DCPH:NASDAQ)
Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 171.29%
- Complete Solaria Inc. (CSLR:NASDAQ), 91.7%
- Mullen Automotive Inc. (MULN:NASDAQ), 81.01%
- Deciphera Pharmaceuticals, Inc. (DCPH:NASDAQ), 72.56%
- Collective Audience Inc. (CAUD:NASDAQ), 57.92%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Lichen China Limited (LICN:NASDAQ), 48.18%
- HWH International Inc. (HWH:NASDAQ), 41.76%
- The OLB Group, Inc. (OLB:NASDAQ), 35.11%
- Sintx Technologies, Inc. (SINT:NASDAQ), 34.9%